Lisata Therapeutics Statistics
NASDAQ: LSTAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
0.8989-0.0111 (-1.22%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Lisata Therapeutics by the numbers
Lisata Therapeutics has a market capitalization of $647,451 based on 720.27K shares outstanding. With trailing EPS of $-28.20, Lisata Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 95.0% below its 50-day average and 97.8% below its 200-day average.
Average daily trading volume is 13.46K shares, or about $12,096 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
LSTA valuation vs. peer median
| Metric | LSTA | Peer median | Difference |
|---|---|---|---|
| Market cap | $647.45K | $799.54K | -19% |
| Avg. volume | 13.46K | 547.80K | -98% |
Peer median across 8 companies: OGEN, SPRC, CDT, MTNB, BDRX, GOVX, SXTC, ARTL.
Valuation
- Market cap
- $647.45K
- Price / sales (latest FY)
- 3.81
- EPS (TTM)
- $-28.20
- Shares outstanding
- 720.27K
Price and trading
- Previous close
- 0.91
- Open
- 0.8827
- Day range
- 0.85 – 0.90
- 52-week range
- 0.85 – 76.05
- 52-week change
- -54.14%
- Beta
- —
- Volume
- 139.26K
- Average volume
- 13.46K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 647.45K
- Forward Pe
- -0.77
- Eps
- -28.20
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 76.05
- Week52 Low
- 0.85
- Avg Volume
- 13,457.00
- Shares Outstanding
- 720.27K
- Ma50
- 18.08
- Ma200
- 41.14
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -98.82%
- Pct From52w Low
- 5.75%